This week in optometry: December 11-December 15

News
Article

Catch up on what happened in optometry during the week of December 11-December 15.

Catch up with what Optometry Times® shared this week:

FDA approves iDose TR from Glaukos for reduction of IOP and ocular hypertension

David Hutton, Managing Editor, Ophthalmology Times

iDose TR, a micro-invasive intraocular implant designed to lower IOP in patients with open-angle glaucoma or ocular hypertension, has received FDA approval following a new drug application (NDA) submission.

Read more...

Parental perspectives on myopia unveiled by The Vision Council

Emily Kaiser Maharjan, Assistant Managing Editor

A research report compiled by The Vision Council reveals that most parents are aware of myopia but remain in the dark about prevalence and how to prevent progression.

Read more...

New tools emerge for the early detection of hydroxychloroquine maculopathy

Kyra Dorgeloh, OD, FAAO; Leena Walker, OD, FAAO

Hydroxychloroquine is considered to have a favorable systemic safety profile, even for long-term use, but poses the risk for retinal toxicity and irreversible vision loss.

Read more...

Topline results from Ersa Phase 2a trial revealed by Tarsus

Martin David Harp, Associate Editor, Ophthalmology Times

TP-03 (lotilaner ophthalmic solution, 0.25%) was approved by the FDA in 2023 under the brand name Xdemvy for the treatment of Demodex blepharitis and is being evaluated as an investigational therapy for the treatment of Meibomian Gland Disease (MGD) in patients with Demodex mites.

Read more...

2023 in review: A review of FDA approvals in eye care this year

Martin David Harp, Associate Editor, Ophthalmology Times; Emily Kaiser Maharjan, Assistant Managing Editor

Eye care witnessed a transformative year with 11 FDA approvals. As the year concludes, there remains a robust pipeline of drugs, setting high expectations for continued advancements in ophthalmological care in 2024 and beyond.

Read more...

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.